Free Trial

Sol-Gel Technologies (SLGL) Competitors

Sol-Gel Technologies logo
$40.32 -0.19 (-0.47%)
Closing price 10/17/2025 03:59 PM Eastern
Extended Trading
$40.32 0.00 (0.00%)
As of 08:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SLGL vs. CHEK, DRCT, NGNE, ENGN, FDMT, DBVT, KRRO, EOLS, BNTC, and YMAB

Should you be buying Sol-Gel Technologies stock or one of its competitors? The main competitors of Sol-Gel Technologies include Check-Cap (CHEK), Direct Digital (DRCT), Neurogene (NGNE), enGene (ENGN), 4D Molecular Therapeutics (FDMT), DBV Technologies (DBVT), Korro Bio (KRRO), Evolus (EOLS), Benitec Biopharma (BNTC), and Y-mAbs Therapeutics (YMAB).

Sol-Gel Technologies vs. Its Competitors

Sol-Gel Technologies (NASDAQ:SLGL) and Check-Cap (NASDAQ:CHEK) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

In the previous week, Check-Cap had 1 more articles in the media than Sol-Gel Technologies. MarketBeat recorded 1 mentions for Check-Cap and 0 mentions for Sol-Gel Technologies. Check-Cap's average media sentiment score of 1.00 beat Sol-Gel Technologies' score of 0.00 indicating that Check-Cap is being referred to more favorably in the news media.

Company Overall Sentiment
Sol-Gel Technologies Neutral
Check-Cap Positive

Sol-Gel Technologies has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500. Comparatively, Check-Cap has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500.

26.2% of Sol-Gel Technologies shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 66.5% of Sol-Gel Technologies shares are held by insiders. Comparatively, 0.5% of Check-Cap shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Sol-Gel Technologies has higher revenue and earnings than Check-Cap. Sol-Gel Technologies is trading at a lower price-to-earnings ratio than Check-Cap, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sol-Gel Technologies$11.54M9.75-$10.58M-$1.23-32.78
Check-CapN/AN/A-$25.15M-$3.00-0.61

Check-Cap has a net margin of 0.00% compared to Sol-Gel Technologies' net margin of -14.25%. Check-Cap's return on equity of 0.00% beat Sol-Gel Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Sol-Gel Technologies-14.25% -11.80% -9.39%
Check-Cap N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sol-Gel Technologies
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Check-Cap
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Sol-Gel Technologies beats Check-Cap on 7 of the 13 factors compared between the two stocks.

Get Sol-Gel Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SLGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SLGL vs. The Competition

MetricSol-Gel TechnologiesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$112.49M$4.44B$6.13B$10.55B
Dividend YieldN/A0.88%5.72%4.83%
P/E Ratio-32.7810.8529.3427.06
Price / Sales9.7521.85595.40132.25
Price / CashN/A7.4625.8230.35
Price / Book3.894.2712.236.58
Net Income-$10.58M-$134.23M$3.33B$276.84M
7 Day Performance0.93%0.32%0.61%-0.72%
1 Month Performance32.20%12.18%6.81%2.16%
1 Year Performance482.24%64.25%58.96%34.63%

Sol-Gel Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SLGL
Sol-Gel Technologies
0.6527 of 5 stars
$40.32
-0.5%
N/A+482.2%$112.49M$11.54M-32.7850Gap Down
CHEK
Check-Cap
0.5614 of 5 stars
$1.91
+3.8%
N/A+27.3%$10.77MN/A-0.6480Positive News
Short Interest ↓
Gap Down
DRCT
Direct Digital
2.3722 of 5 stars
$0.35
+4.6%
$6.00
+1,624.1%
-88.8%$7.49M$62.29M-0.1960Short Interest ↑
NGNE
Neurogene
1.5467 of 5 stars
$31.62
+4.7%
$46.17
+46.0%
-46.6%$431.15M$930K-7.3490
ENGN
enGene
3.0998 of 5 stars
$8.29
-1.2%
$19.50
+135.2%
+3.7%$429.50MN/A-4.3631
FDMT
4D Molecular Therapeutics
3.1727 of 5 stars
$9.67
+8.7%
$30.40
+214.4%
+15.4%$415.65M$40K-2.74120Analyst Revision
High Trading Volume
DBVT
DBV Technologies
1.2361 of 5 stars
$16.42
+9.5%
$14.75
-10.2%
+380.8%$410.93M$4.15M-3.4480Positive News
Gap Up
High Trading Volume
KRRO
Korro Bio
2.0844 of 5 stars
$45.71
+6.4%
$86.83
+90.0%
-47.3%$403.53M$2.27M-4.6970
EOLS
Evolus
3.9305 of 5 stars
$6.00
-2.3%
$21.25
+254.2%
-61.5%$397.17M$266.27M-6.12170
BNTC
Benitec Biopharma
1.2266 of 5 stars
$15.00
+0.5%
$24.80
+65.3%
+36.3%$391.66M$80K-10.2020
YMAB
Y-mAbs Therapeutics
1.332 of 5 stars
$8.61
flat
$9.62
+11.8%
N/A$391.24M$87.68M-17.22150

Related Companies and Tools


This page (NASDAQ:SLGL) was last updated on 10/20/2025 by MarketBeat.com Staff
From Our Partners